Cargando…
Early Peanut Immunotherapy in Children (EPIC) trial: protocol for a pragmatic randomised controlled trial of peanut oral immunotherapy in children under 5 years of age
INTRODUCTION: Food allergy is a major public health challenge in Australia. Despite widespread uptake of infant feeding and allergy prevention guidelines the incidence of peanut allergy in infants has not fallen, and prevalence of peanut allergy in school-aged children continues to rise. Therefore,...
Autores principales: | O'Sullivan, Michael David, Bear, Natasha, Metcalfe, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649730/ https://www.ncbi.nlm.nih.gov/pubmed/37963680 http://dx.doi.org/10.1136/bmjpo-2023-002294 |
Ejemplares similares
-
Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial
por: Michaud, Elodie, et al.
Publicado: (2015) -
Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
por: Chebar Lozinsky, Adriana, et al.
Publicado: (2020) -
Children and caregiver proxy quality of life from peanut oral immunotherapy trials
por: Galvin, Audrey Dunn, et al.
Publicado: (2022) -
Peanut oral immunotherapy: current trends in clinical trials
por: Reinwald, Simone, et al.
Publicado: (2022) -
Peanut immunotherapy
por: Anagnostou, Katherine, et al.
Publicado: (2014)